Home > Healthcare > Analytical Instruments > Lab Equipment and Supplies > Serum Separation Gel Market

Serum Separation Gel Market - By Product (Serum Separation Gel Without Integrated Tubes, Serum Separation Gel with Integrated Tubes), End-use (Hospitals, Blood Banks, Pharmaceutical Companies)– Global Forecast (2024 – 2032)

  • Report ID: GMI8814
  • Published Date: Apr 2024
  • Report Format: PDF

Serum Separation Gel Market Size

Serum Separation Gel Market size was valued at around USD 7.7 billion in 2023 and is anticipated to grow at a CAGR of 5.9% between 2024 and 2032. Serum separation gel is a specialized substance found in blood collection tubes designed to facilitate the separation of serum from whole blood during centrifugation. Typically composed of gel materials such as silicone or inert polymers, it is positioned between the serum-free media layer and the clot activator or anticoagulant layer within the tube. Centrifuging causes the gel to act as a barrier, enabling the clean separation of serum from blood cells.

Serum Separation Gel Market

The increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, and cancer, fueling the demand for diagnostic testing and monitoring. For instance, according to World Health Organization (WHO) in 2022, reported that cancer emerged as a prominent contributor to global mortality, claiming approximately 9.7 million lives globally. Thus, the increasing demand for sophisticated diagnostic equipment such as serum separation gel for precise sample handling is projected to persist, driven by the ongoing requirements of healthcare systems on a global scale.

Furthermore, market growth is attributed to multiple factors, including the rising demand for diagnostic, growing technological advancement in blood collection, and growing adoption of point of care testing.

Serum Separation Gel Market Trends

The ongoing progress in blood testing, which estimated to reach USD 142 billion by 2032, technologies signifies a fundamental change in the methods healthcare providers utilize for collecting and processing patient samples. These advancements encompass various enhancements in collection tube design and the integration of innovative features, all geared towards improving efficiency, preserving sample integrity, and elevating patient comfort.

  • Technological advancements in blood collection methods such as vacuum-sealed collection tubes or integrated separator systems streamline the sample collection process. This efficiency reduces the time and labor required for sample processing, contributing to overall workflow optimization.
  • Some innovative blood collection systems enable the collection of smaller sample volumes, ensuring ample serum yield. This decrease in sample volume requirements proves especially advantageous for pediatric or geriatric patients or situations with limited sample availability.
  • Additionally, advanced blood collection technologies help to minimize the risk of sample hemolysis or contamination ensuring the integrity and purity of serum samples. High-quality samples are crucial for accurate diagnostic testing and reliable results making them essential for healthcare providers and clinical laboratories.

Serum Separation Gel Market Analysis

Serum Separation Gel Market, By Product, 2021 – 2032 (USD Billion)

Based on product, the market is segmented into serum separation gel without integrated tubes and serum separation gel with integrated tubes. The serum separation gel with integrated tubes is estimated to account for USD 8.9 billion by 2032.

  • Integrated serum separation gel tubes eliminate the need for additional processing steps such as manual pipetting or transfer of samples to separate gel tubes. This streamlines the sample processing workflow saving time and reducing the risk of sample handling errors.
  • This frequently necessitates smaller blood volumes for efficient serum separation in contrast to conventional gel tubes. Such an approach offers notable benefits for pediatric, geriatric, or challenging-to-access patients by mitigating discomfort and lowering the likelihood of iatrogenic anemia.
  • Further, many integrated serum separation gel tubes are designed to be compatible with automated sample processing systems. This enables seamless integration into laboratory workflows, increasing throughput, and efficiency while minimizing manual intervention, thereby contributing to the growth of the market.


Serum Separation Gel Market, By End-use (2023)

Based on end-use, the serum separation gel market is segmented into hospitals, blood banks, pharmaceutical companies, and other end-users. The blood banks segment accounted for USD 3.4 billion in 2023.

  • Serum separation gel ensures clean separation of serum from whole blood leading to high-quality serum samples suitable for transfusion purposes. This improves the safety and efficacy of blood products collected and processed by blood banks.
  • With this serum separation gel streamlines the blood processing workflow in blood banks by reducing the need for manual separation methods. This improves operational efficiency, allowing blood banks to process samples more quickly and effectively.
  • By effectively separating serum from cellular components serum separation gel reduces the risk of contamination in blood samples. This is particularly important in blood banking, as maintaining sample integrity is essential for ensuring the safety of transfusion recipients, thereby escalating the growth of the market.


North America Serum Separation Gel Market, 2021 – 2032 (USD Billion)

In 2023, North America held a significant market share of 40.6% in the serum separation gel market and is predicted to witness substantial market growth over the analysis timeline.

  • The region boasts a well-developed healthcare infrastructure, including state-of-the-art clinical laboratories, blood banks, and research institutions. This infrastructure supports the adoption of advanced serum separation gel technologies and facilitates their integration into laboratory workflows.
  • The increasing incidence of chronic diseases such as cardiovascular diseases, diabetes, and cancer has emerged as a significant concern.
  • North America is a hub for technological innovation in the healthcare industry. The region is home to numerous companies and research organizations focused on developing advanced blood collection technologies, including serum separation gel formulations with improved efficiency and performance, thereby propelling the growth of the market.

Serum Separation Gel Market Share

The serum separation gel industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Serum Separation Gel Market Companies

Some of the eminent market participants operating in the serum separation gel industry include:

  • Becton, Dickinson and Company              
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.          
  • Danaher Corporation                    
  • FL MEDICAL s.r.l.     
  • Greiner AG              
  • InterVacTechnology
  • Qiagen N.V.             
  • Sekisui Chemical CO., LTD. 

Serum Separation Gel Industry News:

  • In May 2023, Greiner AG unveiled the VACUETTE CAT Serum Fast Separator Tube, a groundbreaking innovation in blood collection technology. This product revolutionized the process by combining the swiftness of a plasma tube with the premium quality of serum, ensuring minimal erythrocytes post-centrifugation. This advancement underscored Greiner AG's commitment to delivering cutting-edge solutions that enhanced efficiency and accuracy in diagnostic procedures, ultimately benefiting both healthcare professionals and patients alike.

The serum separation gel market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

  • Serum separation gel without integrated tubes                      
  • Serum separation gel with integrated tubes

Market, By End-use

  • Hospitals
  • Blood banks
  • Pharmaceutical companies
  • Other end-users 

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East and Africa


Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The serum separation gel industry crossed USD 7.7 billion in 2023 and is estimated to reach over USD 13 billion by 2032, driven by the increasing prevalence of chronic diseases, such as cardiovascular diseases, diabetes, and cancer.

The blood banks end-use segment in the serum separation gel industry accounted for USD 3.4 billion in 2023 and is set to gain traction by 2032, owing to the ability to improve the safety and efficacy of blood products collected and processed by blood banks.

North America serum separation gel market held a revenue share of 40.6% in 2023 and is predicted to witness substantial growth by 2032, driven by a well-developed healthcare infrastructure, including state-of-the-art clinical laboratories.

Becton, Dickinson and Company, BIOSIGMA S.p.A., Bio-Rad Laboratories, Inc, Cardinal Health, Inc, Danaher Corporation, FL MEDICAL s.r.l. and Greiner AG among others.

Serum Separation Gel Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 160
  • Countries covered: 22
  • Pages: 130
 Download Free Sample